Thoratec Corp (NASDAQ:THOR)
The Company manufactures, develops and markets medical devices used for circulatory support.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
The resent drop of 25% was an overreaction. That was a buying opportunity in my opinion.
Recs
THOR has just recently been approved to market the Heartmate ll pump for destination cardiac patients. This allows hope for many thousands of cardiac patients who might have less than a year to live and who are not elgible for or waiting for a transplant.
Recs
Solid growth company will outperform the S&P
Recs
LT Growth: 24%
EPS Surp: Pos last 2 qtrs
MF: +
Large Volume Increae
Insight, Driehaus, Fid Contra, Veredus, Calamos, Lord Abbett,
Emerald, Kopp, NCM
=BUY!
Recs
Recs
Expect takeover by MDT
Recs
IBD
Recs
Strong fundamentals.
Recs
another strong biotech company thats well run
Recs
People will have bad hearts. Thanks McDonalds
Recs
highlighted in IBD Tech. says way ahead of competition in heart pumps. sounds interesting.
Recs
This company is a lottery ticket but it's priced like the drawing is already complete. Institutions disposed 3% of their holdings last quarter; insiders acquiring (non open market) and doing same. Why bother with this?
Recs
Long term play on aging population.
Recs
Increasing medicare coverage that will allow more hospitals to implant the device, improved new product on the verge of approval, best in class.
Recs
well managed; great performer over past few years
Recs
BTT and DT market have tremendous potential. Will shoot up probably beginning July 2007. Strong potential for a takeover by another company. WIll see $50+ by the end of 2007, if not taken over earlier at a hefty premium.
Recs
Totally robotic heart implant FDA approved. new model in testing,should be approved by year end
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 18 of 18